TEXs can indirectly deliver tumor antigens to dendritic cells, and then activate cytotoxic activities of CD8+ T cells and CD4+ T helper cells, resulting in suppressing tumor growth and resistance to malignant tumor development [50]. The gene discussed is CD4; the disease is neoplasm.